MedrivaPeptide Intelligence
Brief

Evolv Launches Oral Hair Growth Supplement Based on GHK-Cu-Inspired Peptide

Evolv has introduced a new oral dietary supplement, Evolv Grow, designed to support hair growth in both men and women, according to a company announcement published by Chain Drug Review.

EditionFriday, July 3rd, 2026
FocusPeptide news
Reviewed2026-07-03
Editorial review: Medriva pages are written by named contributors, reviewed by clinical or subject-matter experts, and updated as evidence or regulatory status changes.

Evolv Launches Oral Hair Growth Supplement Based on GHK-Cu-Inspired Peptide

Friday, July 3rd, 2026 - Evolv has introduced a new oral dietary supplement, Evolv Grow, designed to support hair growth in both men and women, according to a company announcement published by Chain Drug Review. The product is formulated with a peptide inspired by GHK-Cu, a copper-binding tripeptide studied for its role in tissue repair and hair follicle stimulation.

The company said the supplement is backed by an ongoing placebo-controlled clinical trial evaluating hair growth, density, and thickness. Evolv did not disclose the trial's enrollment size, duration, or primary completion date in the announcement.

GHK-Cu Background

GHK-Cu is a naturally occurring copper peptide that has been investigated in dermatology for wound healing and hair growth applications. While topical formulations containing copper peptides are widely available in cosmetics, oral delivery of GHK-Cu-inspired compounds remains less common. The company did not specify whether Evolv Grow contains GHK-Cu itself or a synthetic analog.

Clinical Evidence Status

Evolv stated that the supplement is "supported by" its ongoing placebo-controlled trial, but the company has not yet published peer-reviewed results. Without completed trial data, the product's efficacy claims remain unverified by independent researchers or regulators. Dietary supplements in the U.S. are not required to receive FDA approval before marketing, though manufacturers must not make drug-like claims without evidence.

Market Context

The launch comes amid growing consumer interest in peptide-based products for hair, skin, and anti-aging purposes. However, regulators and medical experts have repeatedly warned that many peptide products sold as supplements lack rigorous safety and efficacy data. The FDA has signaled increased scrutiny of peptide-containing products, particularly those marketed with therapeutic claims.

Related Reading

  • For more on peptide regulation: /regulatory/fda-warning-letters-tracker/
  • For clinical trial methodology: /clinical-review-methodology/